BIOMAT Database Logo BIOMAT Database Logo

Centrally-induced vasopressor responses to sodium-potassium adenosine triphosphatase inhibitor, ouabain, may be mediated via angiotensin II in the anteroventral third ventricle in the brain. 1984

H Takahashi, and I Iyoda, and K Takeda, and S Sasaki, and H Okajima, and H Yamasaki, and M Yoshimura, and H Ijichi

Central cardiovascular effects of the sodium-potassium adenosine triphosphatase (Na+, K+-ATPase) inhibitor, ouabain, were investigated by injecting it intracerebroventricularly (ICV) using conscious Wistar rats. Ouabain, 0.1-10 micrograms injected ICV, produced dose-related pressor responses attaining peak elevations after about 5 min. To investigate the underlying mechanisms of these central pressor responses, angiotensin II blockers were injected ICV before the injections of ouabain. 1-Sar, 8-Ile angiotensin II (ang IIa), 50 micrograms, given 3 min before the ouabain, abolished the pressor responses to ouabain, 5 micrograms. Angiotensin I converting enzyme inhibitor (CEI, captopril), 100 micrograms, also significantly attenuated the pressor responses to ouabain. Since previous results with ICV injections of ouabain suggested that the pressor responses are mediated via a release of brain angiotension II, and the site of action of brain angiotensin II is believed to be the anteroventral third ventricle (AV3V) area of the brain, ICV injections of ouabain were repeated using rats whose AV3V areas had been destroyed electrically. The pressor responses were smaller in the AV3V lesioned rats than in sham-operated rats. The abdominal sympathetic nerve activity was recorded using three conscious, normotensive Wistar rats. ICV injections of ouabain, 5 micrograms, elicited pressor responses as described above and these were accompanied by a corresponding increase in the nerve firing, lasting for 5-7 min. These responses were again abolished by pretreatment with an angiotensin II antagonist. These results suggest that centrally administered ouabain elicits vasopressor responses which increase peripheral sympathetic nerve activity.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008297 Male Males
D010042 Ouabain A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE. Acocantherin,G-Strophanthin,Acolongifloroside K,G Strophanthin
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D012084 Renin-Angiotensin System A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM. Renin-Angiotensin-Aldosterone System,Renin Angiotensin Aldosterone System,Renin Angiotensin System,System, Renin-Angiotensin,System, Renin-Angiotensin-Aldosterone
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D002552 Cerebral Ventricles Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE). Foramen of Monro,Cerebral Ventricular System,Cerebral Ventricle,Cerebral Ventricular Systems,Monro Foramen,System, Cerebral Ventricular,Systems, Cerebral Ventricular,Ventricle, Cerebral,Ventricles, Cerebral,Ventricular System, Cerebral,Ventricular Systems, Cerebral
D004071 Digitalis Glycosides Glycosides from plants of the genus DIGITALIS. Some of these are useful as cardiotonic and anti-arrhythmia agents. Included also are semi-synthetic derivatives of the naturally occurring glycosides. The term has sometimes been used more broadly to include all CARDIAC GLYCOSIDES, but here is restricted to those related to Digitalis. Glycosides, Digitalis

Related Publications

H Takahashi, and I Iyoda, and K Takeda, and S Sasaki, and H Okajima, and H Yamasaki, and M Yoshimura, and H Ijichi
Excitotoxic lesions of the ventral anteroventral third ventricle and pressor responses to central sodium, ouabain and angiotensin II.
February 1997, Brain research,
H Takahashi, and I Iyoda, and K Takeda, and S Sasaki, and H Okajima, and H Yamasaki, and M Yoshimura, and H Ijichi
Anteroventral third ventricle lesions reduce antidiuretic responses to angiotensin II.
June 1979, The American journal of physiology,
H Takahashi, and I Iyoda, and K Takeda, and S Sasaki, and H Okajima, and H Yamasaki, and M Yoshimura, and H Ijichi
Ouabain- and central sodium-induced hypertension depend on the ventral anteroventral third ventricle region.
January 1999, The American journal of physiology,
H Takahashi, and I Iyoda, and K Takeda, and S Sasaki, and H Okajima, and H Yamasaki, and M Yoshimura, and H Ijichi
Central vasopressor responses to conjugated estrogens in rats may be mediated via a renin-angiotensin system in the brain.
September 1982, The Journal of pharmacology and experimental therapeutics,
H Takahashi, and I Iyoda, and K Takeda, and S Sasaki, and H Okajima, and H Yamasaki, and M Yoshimura, and H Ijichi
Centrally induced vasopressor responses to ouabain in DOCA-salt hypertensive rats.
June 1987, Cardiovascular research,
H Takahashi, and I Iyoda, and K Takeda, and S Sasaki, and H Okajima, and H Yamasaki, and M Yoshimura, and H Ijichi
Detection of a ouabain-induced structural change in the sodium, potassium-adenosine triphosphatase.
February 1977, Biochemistry,
H Takahashi, and I Iyoda, and K Takeda, and S Sasaki, and H Okajima, and H Yamasaki, and M Yoshimura, and H Ijichi
Centrally mediated vasopressor effect of angiotensin II in man.
May 1969, Japanese heart journal,
H Takahashi, and I Iyoda, and K Takeda, and S Sasaki, and H Okajima, and H Yamasaki, and M Yoshimura, and H Ijichi
Specific sodium-22 binding to a purified sodium + potassium adenosine triphosphatase. Inhibition by ouabain.
August 1976, The Journal of biological chemistry,
H Takahashi, and I Iyoda, and K Takeda, and S Sasaki, and H Okajima, and H Yamasaki, and M Yoshimura, and H Ijichi
Localization of angiotensin II receptors along the anteroventral third ventricle area of the rat brain.
March 1987, Brain research,
H Takahashi, and I Iyoda, and K Takeda, and S Sasaki, and H Okajima, and H Yamasaki, and M Yoshimura, and H Ijichi
An allosteric explanation for ouabain-induced time-dependent inhibition of sodium, potassium-adenosine triphosphatase.
November 1970, Archives of biochemistry and biophysics,
Copied contents to your clipboard!